New York A 3693: Relates to brand-name drugs with and without an AB generic equivalent

Status: SUBSTITUTED BY S1350 (as of 2023-03-09)

State: New York · Session: 2023-2024 · Bill: A 3693

Sponsors: David Weprin

View New York A 3693 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.